|
Calcium sulfate | CAS 7778-18-9 | ||
CaSO4 | RTECS WS6920000 | ||
Synonyms & Trade Names Anhydrous calcium sulfate, Anhydrous gypsum, Anhydrous sulfate of lime, Calcium salt of sulfuric acid [Note: Gypsum is the dihydrate form & Plaster of Paris is the hemihydrate form.] |
DOT ID & Guide |
Exposure Limits |
NIOSH REL: TWA 10 mg/m3 (total) TWA 5 mg/m3 (resp) | ||
OSHA PEL: TWA 15 mg/m3 (total) TWA 5 mg/m3 (resp) | |||
IDLH N.D. | Conversion |
Physical Description Odorless, white powder or colorless, crystalline solid. [Note: May have blue, gray, or reddish tinge.] |
|||
MW: 136.1 |
BP: Decomposes |
MLT: 2840°F (Decomposes) |
Sol: 0.3% |
VP: 0 mmHg (approx) |
IP: NA |
|
Sp.Gr: 2.96 |
Fl.P: NA |
UEL: NA |
LEL: NA |
|
Noncombustible Solid | |||
Incompatibilities & Reactivities Diazomethane, aluminum, phosphorus, water [Note: Hygroscopic (i.e., absorbs moisture from the air). Reacts with water to form Gypsum & Plaster of Paris.] |
Measurement Methods NIOSH 0500, 0600 |
Personal Protection & Sanitation Skin: No recommendation Eyes: No recommendation Wash skin: No recommendation Remove: No recommendation Change: No recommendation |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash Breathing: Fresh air |
Respirator Recommendations To be added later | |
Exposure Routes inhalation, skin and/or eye contact | |
Symptoms Irritation eyes, skin, upper respiratory system; conjunctivitis; rhinitis, epistaxis (nosebleed) | |
Target Organs
Eyes, skin, respiratory system |
See also: INTRODUCTION |